Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

XEDAR triggers a specific signaling pathway in cells.

Dutasteride may reduce insulin sensitivity and increase body fat.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Gefitinib therapy can cause unusual hair growth on the nose.

Provenge extends prostate cancer survival by about 4 months.

Cancer treatments often cause skin, nail, and hair problems.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.